Ovid Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Ovid Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Ovid Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Ovid Therapeutics by Connor, Clark & Lunn Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $257k | 84k | 3.05 |
2023-12-31 | $261k | 81k | 3.22 |
2023-09-30 | $312k | 81k | 3.84 |
2023-06-30 | $227k | 69k | 3.28 |
2023-03-31 | $80k | 31k | 2.58 |
2022-12-31 | $74k | 40k | 1.86 |
2022-09-30 | $78k | 43k | 1.83 |
2022-06-30 | $79k | 37k | 2.15 |
2022-03-31 | $273k | 87k | 3.14 |
2021-12-31 | $384k | 120k | 3.21 |
2021-09-30 | $671k | 200k | 3.36 |
2021-06-30 | $1.0M | 258k | 3.91 |
2021-03-31 | $1.0M | 252k | 4.02 |
2020-12-31 | $536k | 232k | 2.31 |
2020-09-30 | $861k | 150k | 5.74 |
2020-06-30 | $1.4M | 190k | 7.37 |
2020-03-31 | $473k | 159k | 2.98 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management